Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1093358

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1093358

Europe Genotyping Market Size, Share & Industry Trends Analysis Report By Product (Reagents & Kits, Instruments, and Software & Services), By Application, By End Use, By Technology, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Genotyping Market would witness market growth of 14.3% CAGR during the forecast period (2022-2028).

These cluster maps depict the origins of cases as well as the time frame in which they developed. This provides a considerably sharper picture of transmission dynamics, leading to better transmission control and prevention. All of these distinct types of genotyping are used in tandem to identify tuberculosis, stop it from spreading, and track down the source of infections. This has aided in the reduction of tuberculosis cases.

Genotyping by sequencing is one form that is utilized in agriculture to help with crop breeding. Single nucleotide polymorphisms (SNPs) are utilized as markers in this study, and RNA sequencing is used to examine gene expression in plants. This sort of genotyping provides information that can be used to improve agriculture by allowing for selective breeding of crops. Alfalfa's cell wall was strengthened through selective breeding, which was achieved through such genotyping. These methods have also led to the finding of genes that confer disease resistance. Wheat has a gene called Yr15 that protects it from a disease known as yellow wheat rust. Yellow wheat rust was therefore prevented via selective breeding for the Yr15 gene, which benefited agriculture.

The improved novel high-throughput nucleic acids analytical techniques in a variety of genetic and systems biology research that use well-phenotype materials, such as those from standardized European biobanks and animal institutions. Massively parallel sequencing technologies, for example, are critical components of modern biomedical research and are capable of revealing molecular and cellular processes underlying complex characteristics and disorders.

Since the genetic recombination, a valid and discriminate approach to genotype Cryptosporidium specimens at the cross-functional and cross-level necessitates the study of many loci, however, there is currently no standardized scheme available. In 2016, 23 scientists with specific skills in either Cryptosporidium genotyping and/or surveillance, epidemiology, or outbreaks met at the Robert Koch Institute in Berlin to discuss the processes for developing a robust, standards-compliant, multi-locus genotyping (MLG) scheme and posit an approach. Respondents selected mobility, biological robustness, type ability, and discriminating power as the most significant features in constructing a multilocus system in a rating exercise comprising performance and convenience criteria. For use with Cryptosporidium, a structured method for marker identification, assessment, verification, deployment, and maintenance was developed and defined, with a focus on Cryptosporidium parvum to help in the investigation of transmission in Europe.

The Germany market dominated the Europe Genotyping Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2027.2 million by 2028. The UK market is exhibiting CAGR of 13.4% during (2022 - 2028). Additionally, The France market would witness a CAGR of 15.1% during (2022 - 2028).

Based on Product, the market is segmented into Reagents & Kits, Instruments, and Software & Services. Based on Application, the market is segmented into Diagnostics & Personalized Medicine, Agricultural Biotechnology, Pharmacogenomics, Animal Genetics, and Others. Based on End Use, the market is segmented into Diagnostics & Research Laboratories, Pharmaceutical & Biopharmaceutical Companies, Academic Institutes, and Others. Based on Technology, the market is segmented into PCR, Sequencing, Capillary Electrophoresis, Microarray, Mass Spectrometry, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific Group, and Fluidigm Corporation.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Reagents & Kits
  • Instruments
  • Software & Services

By Application

  • Reagents & Kits
  • Instruments
  • Software & Services

By End Use

  • Diagnostics & Research Laboratories
  • Pharmaceutical & Biopharmaceutical Companies
  • Academic Institutes
  • Others

By Technology

  • PCR
  • Sequencing
  • Capillary Electrophoresis
  • Microarray
  • Mass Spectrometry
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific Group
  • Fluidigm Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Genotyping Market, by Product
    • 1.4.2 Europe Genotyping Market, by Application
    • 1.4.3 Europe Genotyping Market, by End Use
    • 1.4.4 Europe Genotyping Market, by Technology
    • 1.4.5 Europe Genotyping Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Genotyping Market

Chapter 4. Europe Genotyping Market by Product

  • 4.1 Europe Reagents & Kits Market by Country
  • 4.2 Europe Instruments Market by Country
  • 4.3 Europe Software & Services Market by Country

Chapter 5. Europe Genotyping Market by Application

  • 5.1 Europe Diagnostics & Personalized Medicine Market by Country
  • 5.2 Europe Agricultural Biotechnology Market by Country
  • 5.3 Europe Pharmacogenomics Market by Country
  • 5.4 Europe Animal Genetics Market by Country
  • 5.5 Europe Others Market by Country

Chapter 6. Europe Genotyping Market by End Use

  • 6.1 Europe Diagnostics & Research Laboratories Market by Country
  • 6.2 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country
  • 6.3 Europe Academic Institutes Market by Country
  • 6.4 Europe Others Market by Country

Chapter 7. Europe Genotyping Market by Technology

  • 7.1 Europe PCR Market by Country
  • 7.2 Europe Sequencing Market by Country
  • 7.3 Europe Capillary Electrophoresis Market by Country
  • 7.4 Europe Microarray Market by Country
  • 7.5 Europe Mass Spectrometry Market by Country
  • 7.6 Europe Others Market by Country

Chapter 8. Europe Genotyping Market by Country

  • 8.1 Germany Genotyping Market
    • 8.1.1 Germany Genotyping Market by Product
    • 8.1.2 Germany Genotyping Market by Application
    • 8.1.3 Germany Genotyping Market by End Use
    • 8.1.4 Germany Genotyping Market by Technology
  • 8.2 UK Genotyping Market
    • 8.2.1 UK Genotyping Market by Product
    • 8.2.2 UK Genotyping Market by Application
    • 8.2.3 UK Genotyping Market by End Use
    • 8.2.4 UK Genotyping Market by Technology
  • 8.3 France Genotyping Market
    • 8.3.1 France Genotyping Market by Product
    • 8.3.2 France Genotyping Market by Application
    • 8.3.3 France Genotyping Market by End Use
    • 8.3.4 France Genotyping Market by Technology
  • 8.4 Russia Genotyping Market
    • 8.4.1 Russia Genotyping Market by Product
    • 8.4.2 Russia Genotyping Market by Application
    • 8.4.3 Russia Genotyping Market by End Use
    • 8.4.4 Russia Genotyping Market by Technology
  • 8.5 Spain Genotyping Market
    • 8.5.1 Spain Genotyping Market by Product
    • 8.5.2 Spain Genotyping Market by Application
    • 8.5.3 Spain Genotyping Market by End Use
    • 8.5.4 Spain Genotyping Market by Technology
  • 8.6 Italy Genotyping Market
    • 8.6.1 Italy Genotyping Market by Product
    • 8.6.2 Italy Genotyping Market by Application
    • 8.6.3 Italy Genotyping Market by End Use
    • 8.6.4 Italy Genotyping Market by Technology
  • 8.7 Rest of Europe Genotyping Market
    • 8.7.1 Rest of Europe Genotyping Market by Product
    • 8.7.2 Rest of Europe Genotyping Market by Application
    • 8.7.3 Rest of Europe Genotyping Market by End Use
    • 8.7.4 Rest of Europe Genotyping Market by Technology

Chapter 9. Company Profiles

  • 9.1 F. Hoffmann-La Roche Ltd.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Segmental and Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.1 Recent strategies and developments:
      • 9.1.1.1 Partnerships, Collaborations, and Agreements:
  • 9.2 Danaher Corporation
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Acquisition and Mergers:
  • 9.3 Agilent Technologies, Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
  • 9.4 Thermo Fisher Scientific, Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Product Launches and Product Expansions:
  • 9.5 Qiagen N.V.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 Recent strategies and developments:
      • 9.5.5.1 Partnerships, Collaborations, and Agreements:
  • 9.6 Illumina, Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Regional Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Partnerships, Collaborations, and Agreements:
      • 9.6.5.2 Product Launches and Product Expansions:
  • 9.7 Bio-Rad laboratories, Inc.
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 Recent strategies and developments:
      • 9.7.5.1 Product Launches and Product Expansions:
  • 9.8 Eurofins Scientific Group
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Recent strategies and developments:
      • 9.8.4.1 Acquisition and Mergers:
  • 9.9 Fluidigm Corporation
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional Analysis
    • 9.9.4 Research & Development Expenses

LIST OF TABLES

  • TABLE 1 Europe Genotyping Market, 2018 - 2021, USD Million
  • TABLE 2 Europe Genotyping Market, 2022 - 2028, USD Million
  • TABLE 3 Europe Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 4 Europe Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 5 Europe Reagents & Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 6 Europe Reagents & Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 7 Europe Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 8 Europe Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 9 Europe Software & Services Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Europe Software & Services Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Europe Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 12 Europe Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 13 Europe Diagnostics & Personalized Medicine Market by Country, 2018 - 2021, USD Million
  • TABLE 14 Europe Diagnostics & Personalized Medicine Market by Country, 2022 - 2028, USD Million
  • TABLE 15 Europe Agricultural Biotechnology Market by Country, 2018 - 2021, USD Million
  • TABLE 16 Europe Agricultural Biotechnology Market by Country, 2022 - 2028, USD Million
  • TABLE 17 Europe Pharmacogenomics Market by Country, 2018 - 2021, USD Million
  • TABLE 18 Europe Pharmacogenomics Market by Country, 2022 - 2028, USD Million
  • TABLE 19 Europe Animal Genetics Market by Country, 2018 - 2021, USD Million
  • TABLE 20 Europe Animal Genetics Market by Country, 2022 - 2028, USD Million
  • TABLE 21 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 22 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 23 Europe Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 24 Europe Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 25 Europe Diagnostics & Research Laboratories Market by Country, 2018 - 2021, USD Million
  • TABLE 26 Europe Diagnostics & Research Laboratories Market by Country, 2022 - 2028, USD Million
  • TABLE 27 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 28 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 29 Europe Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 30 Europe Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 31 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 32 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 33 Europe Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 34 Europe Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 35 Europe PCR Market by Country, 2018 - 2021, USD Million
  • TABLE 36 Europe PCR Market by Country, 2022 - 2028, USD Million
  • TABLE 37 Europe Sequencing Market by Country, 2018 - 2021, USD Million
  • TABLE 38 Europe Sequencing Market by Country, 2022 - 2028, USD Million
  • TABLE 39 Europe Capillary Electrophoresis Market by Country, 2018 - 2021, USD Million
  • TABLE 40 Europe Capillary Electrophoresis Market by Country, 2022 - 2028, USD Million
  • TABLE 41 Europe Microarray Market by Country, 2018 - 2021, USD Million
  • TABLE 42 Europe Microarray Market by Country, 2022 - 2028, USD Million
  • TABLE 43 Europe Mass Spectrometry Market by Country, 2018 - 2021, USD Million
  • TABLE 44 Europe Mass Spectrometry Market by Country, 2022 - 2028, USD Million
  • TABLE 45 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 46 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 47 Europe Genotyping Market by Country, 2018 - 2021, USD Million
  • TABLE 48 Europe Genotyping Market by Country, 2022 - 2028, USD Million
  • TABLE 49 Germany Genotyping Market, 2018 - 2021, USD Million
  • TABLE 50 Germany Genotyping Market, 2022 - 2028, USD Million
  • TABLE 51 Germany Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 52 Germany Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 53 Germany Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 54 Germany Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 55 Germany Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 56 Germany Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 57 Germany Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 58 Germany Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 59 UK Genotyping Market, 2018 - 2021, USD Million
  • TABLE 60 UK Genotyping Market, 2022 - 2028, USD Million
  • TABLE 61 UK Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 62 UK Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 63 UK Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 64 UK Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 65 UK Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 66 UK Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 67 UK Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 68 UK Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 69 France Genotyping Market, 2018 - 2021, USD Million
  • TABLE 70 France Genotyping Market, 2022 - 2028, USD Million
  • TABLE 71 France Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 72 France Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 73 France Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 74 France Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 75 France Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 76 France Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 77 France Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 78 France Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 79 Russia Genotyping Market, 2018 - 2021, USD Million
  • TABLE 80 Russia Genotyping Market, 2022 - 2028, USD Million
  • TABLE 81 Russia Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 82 Russia Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 83 Russia Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 84 Russia Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 85 Russia Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 86 Russia Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 87 Russia Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 88 Russia Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 89 Spain Genotyping Market, 2018 - 2021, USD Million
  • TABLE 90 Spain Genotyping Market, 2022 - 2028, USD Million
  • TABLE 91 Spain Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 92 Spain Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 93 Spain Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 94 Spain Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 95 Spain Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 96 Spain Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 97 Spain Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 98 Spain Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 99 Italy Genotyping Market, 2018 - 2021, USD Million
  • TABLE 100 Italy Genotyping Market, 2022 - 2028, USD Million
  • TABLE 101 Italy Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 102 Italy Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 103 Italy Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 104 Italy Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 105 Italy Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 106 Italy Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 107 Italy Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 108 Italy Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 109 Rest of Europe Genotyping Market, 2018 - 2021, USD Million
  • TABLE 110 Rest of Europe Genotyping Market, 2022 - 2028, USD Million
  • TABLE 111 Rest of Europe Genotyping Market by Product, 2018 - 2021, USD Million
  • TABLE 112 Rest of Europe Genotyping Market by Product, 2022 - 2028, USD Million
  • TABLE 113 Rest of Europe Genotyping Market by Application, 2018 - 2021, USD Million
  • TABLE 114 Rest of Europe Genotyping Market by Application, 2022 - 2028, USD Million
  • TABLE 115 Rest of Europe Genotyping Market by End Use, 2018 - 2021, USD Million
  • TABLE 116 Rest of Europe Genotyping Market by End Use, 2022 - 2028, USD Million
  • TABLE 117 Rest of Europe Genotyping Market by Technology, 2018 - 2021, USD Million
  • TABLE 118 Rest of Europe Genotyping Market by Technology, 2022 - 2028, USD Million
  • TABLE 119 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 120 Key Information - Danaher Corporation
  • TABLE 121 key Information - Agilent Technologies, Inc.
  • TABLE 122 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 123 Key Information - Qiagen N.V.
  • TABLE 124 key information - Illumina, Inc.
  • TABLE 125 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 126 Key Information - Eurofins Scientific Group
  • TABLE 127 Key Information - Fluidigm Corporation

List of Figures

  • FIG 1 Methodology for the research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!